• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

Orchid Pharma receives EIR from US FDA for Tamil Nadu plant

financialexpressApril 19, 2017

Tag: Orchid Pharma , FDA

Orchid Pharma said the US health regulator has issued establishment inspection report (EIR) for its manufacturing facility in Tamil Nadu.

The company has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) based on the successful inspection of the formulation manufacturing facility at Irungattukottai, Orchid Pharma said in a filing to BSE.

"The facility was inspected by the USFDA in December 2016," it added.

Upon completion of an inspection by FDA, an EIR is issued which details inspectional findings.

Previous:Mergermarket releases global PMB trend report

Next:Jubilant Life raises Rs 100 cr by issue of commercial papers

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Orchid Pharma receives EIR from US FDA for Tamil Nadu plant | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Irinotecan (FDA)

Irinotecan (FDA)
Fosphenytoin sodium (FDA)

Fosphenytoin sodium (FDA)
Vinorelbine tartrate (FDA)

Vinorelbine tartrate (FDA)
Tacrolimus (FDA)

Tacrolimus (FDA)
Meclozine HCL (FDA)

Meclozine HCL (FDA)
Ramantadine( FDA)

Ramantadine( FDA)
Irinotecan Hcl trihudrate (FDA)

Irinotecan Hcl trihudrate (FDA)
Simvastatin (FDA)

Simvastatin (FDA)
Fluorouracil deoxyriboside( FDA)

Fluorouracil deoxyriboside( FDA)
Praziquantel (FDA)

Praziquantel (FDA)

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service